Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Ca2 concentration" patented technology

Fluorescent protein sensors for detection of analytes

Fluorescent indicators including a binding protein moiety, a donor fluorescent protein moiety, and an acceptor fluorescent protein moiety are described. The binding protein moiety has an analyte-binding region which binds an analyte and causes the indicator to change conformation upon exposure to the analyte. The donor moiety and the acceptor moiety change position relative to each other when the analyte binds to the analyte-binding region. The donor moiety and the acceptor moiety exhibit fluorescence resonance energy transfer when the donor moiety is excited and the distance between the donor moiety and the acceptor moiety is small. The indicators can be used to measure analyte concentrations in samples, such as calcium ion concentrations in cells.
Owner:RGT UNIV OF CALIFORNIA

Medicinal composition for treating diarrhea and preparation thereof

The invention discloses a composition for treating diarrhea and a preparation thereof, relating to a medicinal composition for stopping the diarrhea. The invention also relates to a preparation of the medicinal composition for stopping the diarrhea. The medicinal composition is mainly prepared from the main raw materials of 1 part of Racecadotril and 0.25-25 parts of berberine hydrochloride as well as 0.01-250 parts of auxiliary materials in proportion. The medicinal composition has scientific and reasonable prescription, and can be used for inhibiting the rise of calcium ion concentration in colon smooth muscle cells and improving the motion functional coordination of the intestinal tract to realize the effect on stopping the diarrhea mainly by inhibiting the activity of enkephalinase and further inhibiting the excessive secretion of water and electrolyte via the Racecadotril, and simultaneously by the stronger bactericidal effect of the berberine hydrochloride on escherichia coli, Streptococcus hemolyticus, Diplococcus pneumoniae and the like.
Owner:KUNMING BANGYU PHARMA

Method of reducing impurity content in aqueous salt solution

A method in which an aqueous water-soluble compound solution containing at least one impurity in a slight amount is passed through a column packed with an adsorbent onto which the impurity is selectively adsorbed to thereby remove the impurity from the aqueous solution, wherein an abnormal phenomenon in adsorption chromatography is caused to obtain an elute fraction having a higher concentration of the trace impurity than the raw solution and this fraction is removed. Thus, the trace impurity can be efficiently removed and the water-soluble compound can be obtained in a high-purity state. Applying this method to aqueous sodium chloride solutions gives sodium chloride crystals reduced in impurity concentration. Dissolving such sodium chloride crystals, which have a low potassium ion concentration, in water provides an aqueous sodium chloride solution for medical use. Also provided is a sodium chloride composition for preparing an artificial seawater for use in alga cultivation which is reduced in magnesium ion or calcium ion concentration.
Owner:NAT INST OF ADVANCED IND SCI & TECH

Preventives or Remedies for Hepatopathy

ActiveUS20070219114A1Preventing and alleviating progressionPromoting hepatocyte proliferationOrganic active ingredientsPeptide/protein ingredientsAdditive ingredientHepatectomy
The present invention relates to a preventive or a therapeutic agent for hepatopathy, comprising, as an effective ingredient, a polypeptide derivative having an activity of binding to growth hormone secretagogue receptor and thus elevating intracellular calcium ion concentration, and having one amino acid sequence selected from the group consisting of amino acid sequences represented by SEQ ID NOS: 1 to 22, or an amino acid sequence in which one to several amino acids are deleted, substituted or added at the amino acid residues other that the first to forth amino acid residues from the amino-terminus in the said amino acid sequence, or a pharmacologically acceptable salt thereof. The preventive or the therapeutic agent for hepatopathy in accordance with the present invention is useful as a drug suitable for treating or preventing hepatic diseases such as hepatitis, liver cirrhosis and hepatic insufficiency. Further, the preventive or the therapeutic agent for hepatopathy in accordance with the present invention is also useful as an agent of promoting hepatic regeneration and hepatic function recovery after hepatectomy.
Owner:KANGAWA KENJI

Method for increasing alkaloid content of subprostrate sophora tissue culture seedlings by using calcium ions

The invention discloses a method for increasing the alkaloid content of subprostrate sophora tissue culture seedlings by using calcium ions. The method comprises the following steps that firstly, exogenous calcium ions, naphthylacetic acid and indoleacetic acid are added into a 1 / 2MS culture medium to obtain a first culture medium, and the concentration of the exogenous calcium ions is 0.5-4 timesof the concentration of the calcium ions in the 1 / 2MS culture medium; and secondly, subprostrate sophora aseptic seedlings are inoculated into the first culture medium to be cultured to obtain subprostrate sophora tissue culture seedlings. In the second step, according to the culture conditions, the temperature is 22-28 DEG C, the illumination time is 12 h / d, the illumination intensity is 2500-3000 Lux, and the culture time is 40-50 d. In the first step, the exogenous calcium ions are derived from calcium chloride. In the first step, the first culture medium further comprises saccharose, agarpowder and activated carbon. By introducing the exogenous calcium ions into the culture medium, the content of alkaloid in the subprostrate sophora tissue culture seedlings can be effectively increased.
Owner:GUANGXI BOTANICAL GARDEN OF MEDICINAL PLANTS

Calcium ion selective membrane and preparation method thereof

The invention relates to a calcium ion selective membrane and a preparation method thereof, and belongs to the technical field of blood gas biochemical sensors. The calcium ion selective membrane is used for detecting the concentration of calcium ions in body fluid. The calcium ion selective membrane comprises a macromolecule binding agent, an ion carrier, a carrier solvent, an anion interference agent and a surface active agent. The macromolecule binding agent, the ion carrier, the carrier solvent, the anion interference agent and the surface active agent are dissolved in an ethyl acetate solution, and coating and drying are performed to obtain the calcium ion selective membrane. The prepared calcium ion selective membrane overcomes the defects that the carrier solvent of a traditional ion selective membrane leaks and the strength of the membrane is not high. The prepared calcium ion selective membrane is high in strength, good in tenacity, high in measurement precision, good in long-term stability and low in lower detection limit, the preparation method is simple, the production period is short, the production cost is low, and the calcium ion selective membrane is suitable for large-scale industrial production.
Owner:吴国清

Acid fracturing simulation method considering dynamic process of variable-viscosity acid

ActiveCN110797092AOvercome the defect of low compliance rateFluid removalChemical processes analysis/designAcid fracturingFiltration
The invention discloses an acid fracturing simulation method considering a dynamic process of variable viscosity acid. The method comprises the following steps of: respectively measuring the relationship between the viscosity of the variable-viscosity acid and a shearing rate, temperature, calcium ion concentration, a pH value and surfactant concentration and establishing a variable-viscosity constitutive equation, simulating the flowing and reaction process of the variable-viscosity acid liquid in a fracture system to obtain a pressure profile in the fracture system, simulating and calculating the reaction process of the variable-viscosity acid in a matrix by taking the pressure profile in the fracture system as an inner boundary condition and the ground pressure as an outer boundary condition, simulating the viscosity change condition of the acid liquid in the matrix system and calculating to obtain the filtration speed, and bringing the obtained filtration speed into the pressure profile in the fracture system in the step. The method is used for solving the problem that in the prior art, the acid fracturing simulation technology does not consider the dynamic filtration process of the variable-viscosity acid, so that the coincidence rate of the variable-viscosity acid fracturing simulation fracture length and the actual situation is not high, and the purpose that the acid fracturing fracture form considering the dynamic reduction rate of the variable-viscosity acid can be obtained through simulation is achieved.
Owner:CHENGDU NORTH OIL EXPLORATION DEV TECH

Oocyte activating physical method and fertilization potential evaluation index thereof

The invention relates to an oocyte activating physical method and a fertilization potential evaluation index thereof. An electronic pulse sequence is used for activating the oocyte; the calcium oscillation feature formed by calcium ion concentration change in the endochylema detected in a confocal microscopy is used as an oocyte fertilization potential evaluation index.
Owner:PEOPLES HOSPITAL PEKING UNIV +1

Efficient expression method for novel anticoagulant and thrombolytic dual-function fusion protein

The invention belongs to the field of biological pharmacy and particularly relates to an efficient method for a novel anticoagulant and thrombolytic dual-function fusion protein-hirudin 12 peptide and reteplase fusion protein (HV12p-rPA). According to the method, seven major factors (preparation of a culture medium, inoculation quantity, induction time, rotation speed, induction temperature, a feed supplementing mode and trace elements) in shake-flask culture conditions of escherichia coli engineering bacteria are screened and optimized to determine three most important factors of the rotation speed, temperature and calcium ion concentration, which affect target protein expression amount, and the expression amount of target protein HV12p-rPA is up to 36.15%. The efficient expression method is simple, feasible, efficient, and relatively low in cost, and has a good application value.
Owner:SICHUAN UNIV

Cyano furanone derivative fluorescent probe as well as preparation method and application thereof

The invention discloses a cyano furanone derivative fluorescent probe as well as a preparation method and application thereof. The fluorescent probe has the structure represented as the specification,wherein the R is selected from the following structural formula; the cyano furanone derivative fluorescent probe disclosed by the invention is reliable in performance and simple in synthesis process,and is used as a probe for detecting the concentration of calcium ions in environment and biological samples, the detection process is not interfered by other cations, and the cyano furanone derivative fluorescent probe has high selectivity on the calcium ions; besides, the fluorescent probe can be used for detecting the fluorescence intensity of the fluorescent probe by modifying the length of the contained R group aliphatic chain. Compared with the prior art, the probe has the advantages that lipid-water distribution can be adjusted; meanwhile, due to the fact that the cyano furanone fluorophore has two properties of color development and fluorescence, the probe can perform double-index detection through absorption and fluorescence, and has important scientific significance in diagnosisof calcium ion related diseases such as hypercalcemia and multiple myeloma.
Owner:GUANGZHOU UNIVERSITY

Calcium controlled activation of platelets via electrical stimulation

The present disclosure relates to the generation of an activated platelet product in which one or more of the presence or absence of clots, the timing of clot formation (if present), and / or the mechanical strength of clots (if present) is controlled by the presence or concentration of calcium ions during the activation process. In certain embodiments, the calcium ion concentration is controlled in the presence of pulsed electric fields or a chemical activator (e.g., thrombin) as part of the activation process.
Owner:GENERAL ELECTRIC CO

Carbon dot fluorescent probe for calcium ion detection, and preparation method thereof

The invention discloses a carbon dot fluorescent probe for calcium ion detection, and a preparation method thereof. The carbon dot fluorescent probe comprises a carbon dot and ethylene glycol bis(2-aminoethyl ether)tetraacetic acid modified on the carbon dot. The preparation method comprises the following steps: 1) preparing the carbon dot; and 2) adding the ethylene glycol bis(2-aminoethyl ether)tetraacetic acid into the prepared carbon dot to obtain the carbon dot modified with ethylene glycol bis(2-aminoethyl ether)tetraacetic acid, namely the carbon dot fluorescent probe for calcium ion detection. The carbon dot fluorescent probe for calcium ion detection can detect the concentration of calcium ions in cells, and the carbon dot calcium ion probe prepared by the method has the advantages of cheap raw materials, simple and safe preparation process, and suitableness for large-scale production.
Owner:SUZHOU INST OF BIOMEDICAL ENG & TECH CHINESE ACADEMY OF SCI

Calcium ion concentration measuring device

The present claimed invention provides a calcium ion concentration measuring device that can measure a concentration of a calcium ion in blood of a domestic animal with high accuracy without being affected by temperature on the spot where the blood is collected. The calcium ion concentration measuring device is a portable one for measuring the concentration of the calcium ion in the blood of the domestic animal, and comprises a responsive membrane that selectively reacts with the calcium ion, an internal liquid stored in a space separated from the outside by the responsive membrane, and an internal electrode arranged to be in contact with the internal liquid, and the isothermal intersection point of the internal liquid is set within a range of the concentration of the calcium ion contained in the blood of the domestic animal.
Owner:HORIBA ADVANCED TECHNO

Device for simulating bone mineral loss and application method thereof

The invention relates to a device for simulating bone mineral loss. The device comprises a cylindrical organic glass container and a computer, wherein the top of the cylindrical organic glass container is provided with a cover, and the bottom is provided with a slotted hole I; the cover is provided with a slotted hole II and a slotted hole III; a calcium ion concentration detector is inserted intothe slotted hole II; an in-vitro bone tissue sample fixed at the bottom and a simulated solution for soaking the sample are fixedly loaded in the organic glass container; the organic glass containeris connected with a peristaltic pump through a conduit I and the slotted hole III, and is connected with the peristaltic pump through a conduit II and the slotted hole I; a tail data line of the calcium ion concentration detector is connected with a USB (Universal Serial Bus) interface of the computer through a detector data acquisition unit; software matched with the calcium ion concentration detector is installed in the computer. The invention further discloses an application method for the device. The device is simple in structure, the method is simple and convenient, and obtained data areuniform and reliable; the device can be applied to monitoring and researching of bone mineral loss under a simulated space environment on the ground.
Owner:INST OF MODERN PHYSICS CHINESE ACADEMY OF SCI

Complex of Hepatitis B virus polymerase with p11 and method for controlling movement of the complex in HepG2 cell

Disclosed is a complex of the 11 kDa Ca2+ binding protein of 11 and Hepatitis B virus polymerase (HBVPol) which moves to Promyelocytic Leukemia Nuclear Body (PMLNB). Furthermore, the present invention discloses a method for controlling movement of the HBVPol / p11 complex into the nucleus of HepG2 cell with adjusting of intracellular Ca2+ ion concentration by administrating an agent for controlling calcium ion concentration in HepG2 cells.
Owner:KOREA INST OF SCI & TECH

An Acid Stress Simulation Method Considering the Dynamic Process of Mucosal Acid

ActiveCN110797092BOvercome the defect of low compliance rateFluid removalChemical processes analysis/designAcid fracturingMechanical engineering
The invention discloses an acid pressure simulation method considering the dynamic process of mucovisic acid. The relationship between the viscosity of mucovisic acid and shear rate, temperature, calcium ion concentration, pH value and surfactant concentration is respectively measured, and a mucoviscic constitutive equation is established. ; Simulate the flow and reaction process of viscous acid in the fracture system, and obtain the pressure profile in the fracture system; take the pressure profile in the fracture system as the inner boundary condition, and the ground pressure as the outer boundary condition, simulate the calculation of the variation of viscous acid in the matrix the reaction process; simulate the viscosity change of the acid solution in the matrix system, and calculate the fluid loss velocity; bring the obtained fluid loss velocity into the pressure profile of the fracture system in the step. The invention is used to solve the problem that the acid pressure simulation technology in the prior art does not consider the dynamic filtration process of mucoacid, resulting in a low coincidence rate between the simulated seam length of the mucoacid acid pressure and the actual situation, and realizes that the simulation can be obtained considering the viscous acid. The purpose of acid fracturing fracture morphology after acid dynamic drop rate.
Owner:CHENGDU NORTH OIL EXPLORATION DEV TECH

Method for regulating the preparation of hydroxyapatite with excellent cytocompatibility

The invention provides a method for regulating and preparing hydroxyapatite with excellent cytocompatibility, which is characterized in that it comprises the following steps: Step 1. Prepare Ca(NO 3 ) 2 4H 2 O aqueous solution and (NH 4 ) 2 HPO 4 aqueous solution, and in Ca(NO 3 ) 2 4H 2 Add small molecule amino acids in the O aqueous solution, and the concentration ratio of amino acids and calcium ions is 4:1 or 8:1; Step 2. Set the parameters when dropping and mixing, and (NH 4 ) 2 HPO 4 The mixed aqueous solution of amino acid and amino acid was slowly added dropwise to the stirring Ca(NO 3 ) 2 4H 2 O aqueous solution; step 3. put the obtained precursor into a microwave digestion instrument, set the microwave hydrothermal parameters to react; step 4. carry out centrifugal washing to the solid obtained after the reaction, then freeze-dry to remove excess moisture, and obtain Hydroxyapatite.
Owner:WUHAN UNIV OF TECH

Method and compositions for the identification of agents that have a potential effect against chronic inflammatory diseases

The present invention is based on two important experimental observations: The first observation is that increased extracellular concentrations of ionized calcium are found in erosive arthritis and stimulate monocytic IL-1β release via the CaSR and GPRC6A. Simultaneous stimulation of monocytes with calcium ions and selected TLR ligands results in a 20-fold increased IL1β response compared to lipopolysaccharide (LPS) alone. During the crosstalk between GPCR and TLR signaling, phospholipase C is activated, which triggers calcium dependent potassium channels, resulting in potassium efflux, caspase-1 activation and IL-1β release. The amplification of IL1β secretion at sites of locally increased calcium ion concentrations aggravates rheumatoid arthritis. The second important observation is that both CaSR and GPRC6A, are highly expressed in the synovial membrane of patients with rheumatoid arthritis, but expression of GPRC6A, but not of CaSR, is lower in patients with osteoarthritis (s. FIG. 1). The latter is generally not accompanied by inflammation. Thus, expression of GPRC6A appears to be upregulated in chronic inflammatory situations. Based on these experimental observations the invention provides a method and compositions for the identification of agents that have a potential effect against chronic inflammatory conditions, in particular erosive arthritis and atherosclerosis.
Owner:UNIV LEIPZIG

Mam-specific fluorescence calcium sensor and use thereof

The present disclosure relates to a Mitochondria-Associated endoplasmic reticulum Membrane (MAM)-specific fluorescence calcium sensor and the use thereof. The present disclosure can surmount the limitations of a conventional technique in that verification of calcium migration through MAM requires separate measurements of calcium ion concentrations within ER and mitochondria and situational explanations of the phenomena, and can directly measure concentrations in the paths through which calcium ions move to exclude influences on calcium ion changes through numerous different calcium ion channels existing in mitochondria, thereby providing a convenient and accurate MAM-specific calcium ion sensor.
Owner:POSTECH ACAD IND FOUND

Blood purification device

Provided is a blood purification device that comprises a blood circuit, a blood purifier, a citric acid solution supplying means, and a calcium solution supplying means. The blood purification deviceis configured so as to: estimate a calcium reduction quantity for reduction in the blood circuit overall, including a removal quantity of calcium to be removed with the blood purifier when blood of atarget calcium ion concentration flows through the blood circuit, on the basis of a target calcium ion concentration of patient blood that has been inputted; calculate a supplied quantity of calcium solution to be supplied to the blood circuit on the basis of the calcium reduction quantity; and supply the calcium solution to the blood circuit with the calcium solution supplying means on the basisof the supplied quantity of calcium solution.
Owner:ASAHI KASEI MEDICAL CO LTD

Method and compositions for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker

ActiveUS20190274992A1Favorable broad spectrum of antiviral propertySuppress intracellular replicationAntibacterial agentsAntiviralsAntigenDisease
In the broadest aspect, the invention provides a composition for and a method of prophylactic and / or therapeutic treatment of a animal / mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of viral protein translation, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof, and a pharmaceutical acceptable diluent or carrier; and / or is caused by damage to the animal / mammal by a pathological immune response to antigens.
Owner:DR KENNETH ADAMS MEDICINE PROFESSIONAL CORPORATIO

Method for evaluating scale inhibition performance of oil well shaft capsule scale inhibition particles on calcium carbonate scale

The invention provides a method for evaluating scale inhibition performance of oil well shaft capsule scale inhibition particles on calcium carbonate scale. The method comprises the following steps: simulating the composition of oilfield formation water, and respectively measuring the calcium ion concentration in a capsule scale inhibition particle added sample to be measured, the calcium ion concentration in a capsule scale inhibition particle not added sample to be measured and the calcium ion concentration in a capsule scale inhibition particle not added solution B blank sample to be measured under simulated formation conditions to obtain the calcium carbonate scale inhibition rate. The mixing ratio of a solution A to a solution B is determined through a precipitation method or scale scaling prediction software, so the method accords with the practical conditions of oilfield production; and an anti-scaling agent evaluated according to the ratio can be used in different development periods of a whole shaft or a gathering and transportation station. The method can scientifically guide the oil well shaft capsule scale inhibition particle filling technology, and has the advantages of simplicity in operation, low requirements on detection personnel, low detection cost, strong operability of oil production units, and facilitation of promotion.
Owner:PETROCHINA CO LTD

Method and device for monitoring and adjusting regional citrate anticoagulation

ActiveCN111494745AAvoid low or high blood gas free calcium concentrationsHigh concentration of free calcium ion in blood gasDiagnostic signal processingOther blood circulation devicesBlood gas testAnti coagulation
The invention provides a method and device for monitoring and adjusting regional citrate anticoagulation. The method comprises the steps of: constructing a citrate monitoring and adjusting model basedon a citrate dosage pumping value of a sample, a filtered blood gas free calcium ion influence parameter value, and a filtered blood gas free calcium ion concentration; inputting a to-be-adjusted citrate dosage pumping value of a target patient and a configured value of the filtered blood gas free calcium ion influence parameter into the citrate monitoring and adjusting model to obtain a filteredblood gas free calcium ion predicted concentration of the target patient; querying a mapping relationship between the filtered blood gas free calcium ion concentration and a citrate dosage pumping value adjustment strategy, and acquiring a citrate dosage value adjustment strategy mapped by the filtered blood gas free calcium ion predicted concentration; and adjusting the to-be-adjusted citrate dosage pumping value according to the citrate dosage value adjustment strategy to obtain a citrate dosage pumping target value of the target patient, and conducting pumping according to the citric aciddosage pumping target value, thus effectively improving the anticoagulation effect and treatment safety.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL CHINESE ACAD OF MEDICAL SCI +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products